We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$13.5B
AUM Growth
-$537M
Cap. Flow
-$203M
Cap. Flow %
-1.51%
Top 10 Hldgs %
19.68%
Holding
385
New
13
Increased
113
Reduced
185
Closed
7

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$46.3M
2
QCOM icon
Qualcomm
QCOM
+$36.9M
3
ATKR icon
Atkore
ATKR
+$27.5M
4
WTRG icon
Essential Utilities
WTRG
+$26.1M
5
HALO icon
Halozyme
HALO
+$19.4M

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$43.2M
2
CPE
Callon Petroleum Company
CPE
+$35.4M
3
UMBF icon
UMB Financial
UMBF
+$31M
4
SLB icon
SLB Ltd
SLB
+$30.8M
5
JPM icon
JPMorgan Chase
JPM
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 24.52%
2 Financials 14.32%
3 Healthcare 14.05%
4 Industrials 13.81%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVB
176
DELISTED
AvalonBay Communities
AVB
$16.5M 0.12%
79,849
-10
-0% -$1.93K
ATRI
177
DELISTED
Atrion Corp
ATRI
$16.2M 0.12%
35,729
-73
-0.2% -$31.9K
HD icon
178
Home Depot
HD
$306B
$16.1M 0.12%
46,786
-18,293
-28% -$6.24M
BKR icon
179
Baker Hughes
BKR
$56.2B
$15.4M 0.11%
436,995
-43,000
-9% -$1.41M
CLB icon
180
Core Laboratories
CLB
$573M
$14.8M 0.11%
729,760
+9,468
+1% +$168K
PNC icon
181
PNC Financial Services
PNC
$96B
$14M 0.1%
90,025
-5,922
-6% -$918K
EW icon
182
Edwards Lifesciences
EW
$49.4B
$13.8M 0.1%
149,703
BALL icon
183
Ball Corp
BALL
$16.1B
$13.4M 0.1%
222,770
-25,605
-10% -$1.71M
AMGN icon
184
Amgen
AMGN
$204B
$13.3M 0.1%
42,710
-890
-2% -$261K
ANSS
185
DELISTED
Ansys
ANSS
$13.3M 0.1%
41,272
+7,468
+22% +$2.45M
EG icon
186
Everest Group
EG
$14.5B
$12.5M 0.09%
32,862
-5,001
-13% -$1.89M
VSGX icon
187
Vanguard ESG International Stock ETF
VSGX
$6.69B
$12.3M 0.09%
214,481
-6,109
-3% -$349K
DG icon
188
Dollar General
DG
$27.9B
$12.1M 0.09%
91,137
-105,850
-54% -$14.8M
DHR icon
189
Danaher
DHR
$146B
$11.5M 0.09%
46,068
-578
-1% -$146K
AME icon
190
Ametek
AME
$53.9B
$11.4M 0.08%
68,535
+1,485
+2% +$257K
DHI icon
191
D.R. Horton
DHI
$39.2B
$11.4M 0.08%
+81,040
New +$11.9M
LMT icon
192
Lockheed Martin
LMT
$124B
$11.3M 0.08%
+24,242
New +$11.2M
TJX icon
193
TJX Companies
TJX
$136B
$11M 0.08%
100,302
+15
+0% +$1.51K
VZ icon
194
Verizon
VZ
$214B
$11M 0.08%
267,319
-6,618
-2% -$267K
MDT icon
195
Medtronic
MDT
$120B
$10.9M 0.08%
138,660
-3,705
-3% -$304K
VWO icon
196
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$10.9M 0.08%
249,059
+75,125
+43% +$3.24M
EA
197
DELISTED
Electronic Arts
EA
$10.6M 0.08%
75,785
-40,820
-35% -$5.38M
ULTA icon
198
Ulta Beauty
ULTA
$23.3B
$9.85M 0.07%
25,517
+510
+2% +$207K
STE icon
199
Steris
STE
$20.7B
$9.83M 0.07%
44,794
+880
+2% +$191K
WEC icon
200
WEC Energy
WEC
$33.8B
$9.14M 0.07%
116,546
+645
+0.6% +$52.4K

Similar funds

Boston Trust Walden's Q2 2024 Portfolio in Review

As of Q2 2024, Boston Trust Walden held 385 positions worth $13.5B, down 3.8% from $14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2024 filing shows 13 new, 113 increased, 185 reduced and 7 closed positions. Its largest new stake was Atkore: 172,729 shares worth $23.3M. The largest sale was Medpace, an estimated $43.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2024 buy was Atkore: 172,729 shares worth $23.3M.
  • Boston Trust Walden added most to NVIDIA in Q2 2024, an estimated $46.3M increase.
  • Boston Trust Walden's biggest Q2 2024 reduction was Medpace, cutting an estimated $43.2M.
  • Boston Trust Walden fully exited Callon Petroleum Company in Q2 2024, selling an estimated $35.4M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $13.5B portfolio in Q2 2024.
  • Boston Trust Walden opened 13 new positions and closed 7 in Q2 2024.
  • Boston Trust Walden's portfolio value fell 3.8% quarter-over-quarter to $13.5B.

Based on Boston Trust Walden's 13F filing for Q2 2024, filed 19 Jul 2024.